Search

Your search keyword '"Javaheri, Ali"' showing total 350 results

Search Constraints

Start Over You searched for: Author "Javaheri, Ali" Remove constraint Author: "Javaheri, Ali"
350 results on '"Javaheri, Ali"'

Search Results

1. Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk

2. Proteome-Wide Genetic Investigation of Large Artery Stiffness

3. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

4. Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19

6. Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension

7. SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy

10. Cardiac radiation improves ventricular function in mice and humans with cardiomyopathy

11. Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction

12. Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

13. Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury

17. TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte Homeostasis

18. Fueling the Heart: What Are the Optimal Dietary Strategies in Heart Failure?

19. Prognostic Significance and Biologic Associations of Senescence-Associated Secretory Phenotype Biomarkers in Heart Failure.

20. Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction.

21. Proteomic Associations of Adverse Outcomes in Human Heart Failure

23. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

24. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

28. Proteomic Correlates And Prognostic Significance Of Kidney Injury In Heart Failure With Preserved Ejection Fraction

29. Proteomic Associations Of N-terminal-pro Hormone Bnp In Heart Failure With Preserved Ejection Fraction In Two Cohorts

33. Heterogeneous cardiac sympathetic innervation gradients promote arrhythmogenesis in murine dilated cardiomyopathy

38. Contributors

39. Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure

41. A Critical Role for ERO1α in Arterial Thrombosis and Ischemic Stroke

43. Differences in radiation-induced heart dysfunction in male versus female rats

48. PROTEOMIC CORRELATES OF PLASMA POTASSIUM (K+) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)

49. URINARY PROTEINS LEVELS ASSOCIATED WITH OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION

50. PROTEOMIC ASSOCIATIONS OF N-TERMINAL (NT)-PRO HORMONE BNP (NT-PROBNP) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)

Catalog

Books, media, physical & digital resources